GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Beginning Cash Position

Notable Labs (Notable Labs) Beginning Cash Position : $1.58 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Beginning Cash Position?

Notable Labs's Beginning Cash Position for the quarter that ended in Dec. 2023 was $1.58 Mil.

Notable Labs's quarterly Beginning Cash Position increased from Dec. 2021 ($1.63 Mil) to Dec. 2022 ($2.40 Mil) but then declined from Dec. 2022 ($2.40 Mil) to Dec. 2023 ($1.58 Mil).

Notable Labs's annual Beginning Cash Position increased from Dec. 2021 ($1.63 Mil) to Dec. 2022 ($2.40 Mil) but then declined from Dec. 2022 ($2.40 Mil) to Dec. 2023 ($1.58 Mil).


Notable Labs Beginning Cash Position Historical Data

The historical data trend for Notable Labs's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Beginning Cash Position Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Beginning Cash Position
1.63 2.40 1.58

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Beginning Cash Position 1.63 2.40 1.58

Notable Labs Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Notable Labs Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Notable Labs's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.